We are a biotech start-up, based in Oxford, UK, engineering proprietary protein-based technology to produce innovative new therapies.
Our technology has the potential to deliver enhanced vaccines and other therapeutics, and we are committed to advancing it in order to help people around the world lead healthier lives.
Our first development programme produced a novel vaccine platform and we are currently exploring the use of related technology for novel oncology therapeutics. Our protein lattice systems offer the potential for targeted drug delivery, binding selectively to cells and reducing side effects.
WHAT WE DO
Founded in 2021, we are a team of protein engineers combining our know-how and experience with recent developments in AI to produce exciting new therapeutic platforms.
In 2022, a government-funded SBRI R&D contract allowed us to expand our team and invest in our Oxford-based research and development capabilities.
Building on existing IP, we are now enhancing our core technology with AI-guided protein design. As this nascent technology continues to mature, we seek to secure a position at the forefront of the sector.
GET IN TOUCH
BioEscalator Innovation Building, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ